The prevalence of liver steatosis, streatohepatitis and inflammation activity in a cohort of compensated HCV liver cirrhosis patients, according to FibroMax

Background: The diagnosis of liver cirrhosis is based on clinical evidence of liver disease, laboratory abnormalities, liver stiffness assessed by noninvasive techniques such as elastography based techniques and biological tests. Aim: The aim of this study was to evaluate the prevalence of liver steatosis, fibrosis, streatohepatitis and inflammation activity as assessed by FibroMax in a cohort of compensated HCV liver cirrhosis. Material and methods: We performed a prospective study, including 109 patients diagnosed with HCV liver cirrhosis by means of elastography techniques, by clinical, biologic or endoscopic…